Zobrazeno 1 - 10
of 276
pro vyhledávání: '"Lisa Bodei"'
Autor:
Anna Malczewska, Magdalena Witkowska, Karolina Makulik, Agnes Bocian, Agata Walter, Joanna Pilch-Kowalczyk, Wojciech Zajęcki, Lisa Bodei, Kjell Oberg, Beata Kos-Kudła
Publikováno v:
Endocrine Connections, Vol 8, Iss 4, Pp 442-453 (2019)
Introduction: Current monoanalyte biomarkers are ineffective in gastroenteropancreatic neuroendocrine tumors (GEP-NETs). NETest, a novel multianalyte signature, provides molecular information relevant to disease biology. Aim(s): Independently validat
Externí odkaz:
https://doaj.org/article/18f338e04dc146a1927805565379fc97
Autor:
Mark Kidd, Ignat A Drozdov, Somer Matar, Nicole Gurunlian, Nicholas J Ferranti, Anna Malczewska, Philip Bennett, Lisa Bodei, Irvin M Modlin
Publikováno v:
PLoS ONE, Vol 14, Iss 6, p e0218592 (2019)
BACKGROUND:Multigene-based PCR tests are time-consuming and limiting aspects of the protocol include increased risk of operator-based variation. In addition, such protocols are complex to transfer and reproduce between laboratories. AIMS:Evaluate the
Externí odkaz:
https://doaj.org/article/e26ca457818043c9a8830433ce6ce5b4
Autor:
Kjell Oberg, Eric Krenning, Anders Sundin, Lisa Bodei, Mark Kidd, Margot Tesselaar, Valentina Ambrosini, Richard P Baum, Matthew Kulke, Marianne Pavel, Jaroslaw Cwikla, Ignat Drozdov, Massimo Falconi, Nicola Fazio, Andrea Frilling, Robert Jensen, Klaus Koopmans, Tiny Korse, Dik Kwekkeboom, Helmut Maecke, Giovanni Paganelli, Ramon Salazar, Stefano Severi, Jonathan Strosberg, Vikas Prasad, Aldo Scarpa, Ashley Grossman, Annemeik Walenkamp, Mauro Cives, Irene Virgolini, Andreas Kjaer, Irvin M Modlin
Publikováno v:
Endocrine Connections, Vol 5, Iss 5, Pp 174-187 (2016)
The complexity of the clinical management of neuroendocrine neoplasia (NEN) is exacerbated by limitations in imaging modalities and a paucity of clinically useful biomarkers. Limitations in currently available imaging modalities reflect difficulties
Externí odkaz:
https://doaj.org/article/5d8a8bed100240668fb5e3ecc362659c
Publikováno v:
Cellular and Molecular Gastroenterology and Hepatology, Vol 1, Iss 2, Pp 131-153 (2015)
Gastroenteropancreatic neuroendocrine neoplasms (GEP-NEN), considered a heterogeneous neoplasia, exhibit ill-defined pathobiology and protean symptomatology and are ubiquitous in location. They are difficult to diagnose, challenging to manage, and ou
Externí odkaz:
https://doaj.org/article/b1ac85185c6243748c49049f06d5b7d7
Autor:
Vetri Sudar Jayaprakasam, Lisa Bodei
Publikováno v:
PET Clinics. 18:267-286
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::53a5e0426d5133b0cd8a085737b7b9c2
https://doi.org/10.1016/j.cpet.2022.11.009
https://doi.org/10.1016/j.cpet.2022.11.009
Publikováno v:
Journal of Nuclear Medicine. 64:8-11
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1b18df1acce9228bebeb982c2a49f435
https://doi.org/10.2967/jnumed.122.265135
https://doi.org/10.2967/jnumed.122.265135
Autor:
Lisa Bodei, Nitya Raj, Richard K. Do, Audrey Mauguen, Simone Krebs, Diane Reidy-Lagunes, Heiko Schöder
Publikováno v:
Journal of Nuclear Medicine. 64:567-573
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c8e15226bea685da2d3af5012968967e
https://doi.org/10.2967/jnumed.122.264363
https://doi.org/10.2967/jnumed.122.264363
Publikováno v:
Nature Reviews Clinical Oncology. 19:534-550
Structural imaging remains an essential component of diagnosis, staging and response assessment in patients with cancer; however, as clinicians increasingly seek to noninvasively investigate tumour phenotypes and evaluate functional and molecular res
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::588e71c5164cbe1d70e0d68dae857670
https://doi.org/10.1038/s41571-022-00652-y
https://doi.org/10.1038/s41571-022-00652-y
Autor:
Charito Love, Neil B. Desai, Tony Abraham, Kevin P. Banks, Lisa Bodei, Thomas Boike, Richard K.J. Brown, David L. Bushnell, Lorraine E. DeBlanche, Michael M. Dominello, Tony Francis, Erin C. Grady, Robert F. Hobbs, Thomas A. Hope, Jeffrey S. Kempf, Daniel A. Pryma, William Rule, Bital Savir-Baruch, Ila Sethi, Rathan M. Subramaniam, Ying Xiao, Naomi R. Schechter
Publikováno v:
Clinical Nuclear Medicine. 47:503-511
This practice parameter (PP) for Lutetium-177 (Lu-177) DOTATATE peptide receptor radionuclide therapy (PRRT) aims to guide authorized users in selection of appropriate adult candidates with gastroeneropancreatic neuroendocrine tumors (GEP-NETs) from
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c03653d4bd4791cf4922b6137bae3e3b
https://doi.org/10.1097/rlu.0000000000004182
https://doi.org/10.1097/rlu.0000000000004182
Autor:
Clemens Kratochwil, Wolfgang P. Fendler, Matthias Eiber, Michael S. Hofman, Louise Emmett, Jeremie Calais, Joseph R. Osborne, Amir Iravani, Phillip Koo, Liza Lindenberg, Richard P. Baum, Murat Fani Bozkurt, Roberto C. Delgado Bolton, Samer Ezziddin, Flavio Forrer, Rodney J. Hicks, Thomas A. Hope, Levent Kabasakal, Mark Konijnenberg, Klaus Kopka, Michael Lassmann, Felix M. Mottaghy, Wim J. G. Oyen, Kambiz Rahbar, Heiko Schoder, Irene Virgolini, Lisa Bodei, Stefano Fanti, Uwe Haberkorn, Ken Hermann
Publikováno v:
European Journal of Nuclear Medicine and Molecular Imaging. Springer-Verlag
European Journal of Nuclear Medicine and Molecular Imaging, 50, 9, pp. 2830-2845
European journal of nuclear medicine and molecular imaging, vol 50, iss 9
European Journal of Nuclear Medicine and Molecular Imaging, 50, 9, pp. 2830-2845
European journal of nuclear medicine and molecular imaging, vol 50, iss 9
Prostate-specific membrane antigen (PSMA) is expressed by the majority of clinically significant prostate adenocarcinomas, and patients with target-positive disease can easily be identified by PSMA PET imaging. Promising results with PSMA-targeted ra
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d2bbc72da30d073fb429dcfb7f81700
https://doi.org/10.1007/s00259-023-06255-8
https://doi.org/10.1007/s00259-023-06255-8